Showing results (71-80 of 355) with videos related to

Sort By:
Pageof 36
World Journal of Urology|June 14, 2019
Quality improvement initiative to reduce variability and improve stewardship of antimicrobial prophylaxis for transrectal prostate needle biopsyPedro Recabal, Taehyoung Lee, Emily Vertosick, et al.
Urologic Oncology|October 17, 2017
Concordance between patient-reported and physician-reported sexual function after radical prostatectomyAlan E Thong, Bing Ying Poon, Justin K Lee, et al.
Clinical Trials (London, England)|July 5, 2023
A randomized comparison of two-stage versus traditional one-stage consent for a low-stakes randomized trialAndrew J Vickers, Emily A Vertosick, Mia Austria, et al.
BJU International|May 1, 2012
The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening TrialMaria Frånlund, Sigrid Carlsson, Johan Stranne, et al.
Deutsches Arzteblatt International|April 9, 2026
The Proposed Introduction of a Prostate Cancer Screening Program in Germany: Procedure, Necessary Studies before Implementation, Benefits, and RisksPeter Albers, Sigrid Carlsson, Agne Krilaviciute, et al.
European Urology Oncology|March 18, 2026
Introducing Key Performance Metrics for Assessing the Benefits and Harm of the Prostate Cancer Diagnostic PathwayAnwar R Padhani, Sigrid Carlsson, Ola Bratt, et al.
Urology Practice|August 28, 2024
Targeted Ablation Using Ultrasound-Guided Irreversible Electroporation of Index Tumors (TARGET Study): Prospective Development Study Evaluating Safety, Patient-Reported Outcomes, and Oncologic EfficacyJonathan Fainberg, Taehyoung Lee, Emily A Vertosick, et al.
JCO Oncology Practice|July 1, 2026
Patient Engagement With an Electronic Patient-Reported Outcomes Tool Evaluating Hospital Discharge Readiness After Cancer SurgeryJennifer R Cracchiolo, Richard S Matulewicz, Norma E Farrow, et al.
The Journal of Urology|April 27, 2016
Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate CancerKatie S Murray, Behfar Ehdaie, John Musser, et al.
MDM Policy & Practice|March 16, 2023
Patient Perceptions of a Decision Support Tool for Men with Localized Prostate CancerMia Austria, Colin Kimberlin, Tiffany Le, et al.
Pageof 36